CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
111 hedge funds and large institutions have $255M invested in Concert Pharmaceuticals, Inc. in 2018 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 42 increasing their positions, 40 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
53% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 15
Holders
111
Holding in Top 10
–
Calls
$331K
Puts
$583K
Top Buyers
| 1 | +$8.38M | |
| 2 | +$1.87M | |
| 3 | +$1.84M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.36M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$1.35M |
Top Sellers
| 1 | -$5.33M | |
| 2 | -$3.34M | |
| 3 | -$2.9M | |
| 4 |
Millennium Management
New York
|
-$1.76M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$1.21M |